Effraimidis G, Knigge U, Rossing M, et al. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs). Semin Cancer Biol. 2022;79:141–62.

Article  CAS  PubMed  Google Scholar 

Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol. 2022;33:115–54.

Article  CAS  PubMed  Google Scholar 

Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813–29.

Article  CAS  PubMed  Google Scholar 

Díaz-López S, Jiménez-Castro J, Robles-Barraza CE, et al. Mixed neuroendocrine non-neuroendocrine neoplasms in gastroenteropancreatic tract. World J Gastrointest Oncol. 2024;16:1166–79.

Article  PubMed  PubMed Central  Google Scholar 

Kim J, Lee WJ, Lee SH, et al. Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours. Dig Liver Dis. 2011;43(12):965–70.

Article  PubMed  Google Scholar 

Lee SW, Lee IS, Cho YK, et al. A case of mixed adenoneuroendocrine carcinoma of the common bile duct: initially diagnosed as cholangiocarcinoma. Korean J Pathol. 2014;48:445–8.

Article  PubMed  PubMed Central  Google Scholar 

Maeda T, Yugawa K, Kinjo N, et al. Mixed adenoneuroendocrine carcinoma of the distal bile duct: a case report. Surg Case Rep. 2020;6:160.

Article  PubMed  PubMed Central  Google Scholar 

Kaino M, Kaino S, Goma W, et al. A case of mixed neuroendocrine non-neuroendocrine neoplasm of the distal bile duct with biliary intraepithelial neoplasia. Clin J Gastroenterol. 2021;14:297–303.

Article  PubMed  Google Scholar 

Kurumaya H, Ohta G, Nakanuma Y. Endocrine cells in the intrahepatic biliary tree in normal livers and hepatolithiasis. Arch Pathol Lab Med. 1989;113:143–7.

CAS  PubMed  Google Scholar 

Zhang D, Zheng Lu, Sun W, et al. A Case of Neuroendocrine Tumor of the Common Bile Duct. Chin Med J. 2018;98:2291–2291.

Google Scholar 

Harada K, Sato Y, Ikeda H, et al. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs. Virchows Arch. 2012;460:281–9.

Article  PubMed  Google Scholar 

Shintaku M, Kataoka K, Kawabata K. Mixed adenoneuroendocrine carcinoma of the gallbladder with squamous cell carcinomatous and osteosarcomatous differentiation: report of a case. Pathol Int. 2013;63:113–9.

Article  PubMed  Google Scholar 

Jiang C, Yao H, Zhang Q, et al. Clinicopathological characteristics of mixed neuroendocrine-non-neuroendocrine neoplasms in gastrointestinal tract. Pathol Res Pract. 2023;243: 154373.

Article  CAS  PubMed  Google Scholar 

Frizziero M, Chakrabarty B, Nagy B, et al. Mixed neuroendocrine non-neuroendocrine neoplasms: A systematic review of a controversial and underestimated diagnosis. J Clin Med. 2020;9:273.

Article  PubMed  PubMed Central  Google Scholar 

Priyanka Akhilesh S, Kamal Sunder Y, Chandralekha T, et al. Common hepatic duct mixed adenoneuroendocrine carcinoma masquerading as cholangiocarcinoma. Case Rep Gastrointest Med. 2016;2016:4827050.

PubMed  PubMed Central  Google Scholar 

Hennedige TP, Neo WT, Venkatesh SK. Imaging of malignancies of the biliary tract- an update. Cancer Imaging. 2014;14:14.

Article  PubMed  PubMed Central  Google Scholar 

Zhang C, Shen S, Zheng B, et al. Research advances in extrahepatic biliary neuroendocrine neoplasms[J]. Chinese J General Surg. 2022;37:71–4.

Google Scholar 

Yang G, Li D, Zheng F, et al. Long-term disease free survival of gastric mixed adenoneuroendocrine carcinoma treated with multimodality therapy: A case report. Mol Clin Oncol. 2018;8:653–6.

PubMed  PubMed Central  Google Scholar 

De Mestier L, Cros J. Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN). Ann Endocrinol (Paris). 2019;80:172–3.

Article  PubMed  Google Scholar 

Huang YC, Yang NN, Chen HC, et al. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients. World J Gastroenterol. 2021;27:624–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

La Salvia A, Modica R, Rossi RE, et al. Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists. Cancer Treat Rev. 2023;117: 102560.

Article  PubMed  Google Scholar 

Strosberg JR, Caplin ME, Kunz PL, et al. 177Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021;22:1752–63.

Article  CAS  PubMed  Google Scholar 

Song W, Chen W, Zhang S, et al. Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy. Diagn Pathol. 2012;7:163.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chorath J, Placencio-Hickok VR, Guan M, et al. Durable response to carboplatin, etoposide, nivolumab, and ipilimumab in metastatic high-grade neuroendocrine carcinoma of the gallbladder. Pancreas. 2020;49:e19–20.

Article  PubMed  Google Scholar 

Lou L, Lv F, Wu X, et al. Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN). Eur J Surg Oncol. 2021;47:323–30.

Article  PubMed  Google Scholar 

Liu L, Li Q, Liu W, et al. Gastric mixed neuroendocrine non-neuroendocrine neoplasms. Front Oncol. 2024;14:1335760.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sahnane N, Furlan D, Monti M, et al. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity. Endocr Relat Cancer. 2015;22:35–45.

Article  CAS  PubMed  Google Scholar